-
CDC Approves Updated Pfizer, Moderna Covid Booster Shots
The CDC voted Thursday to recommend updated versions of both the Pfizer and Moderna coronavirus vaccine boosters, paving way for a widespread rollout as early as next week.
-
FDA Authorizes Covid Shots for Children Under 5, Sends to CDC for Vote
The FDA authorized the first COVID-19 vaccination for children as young as six months on Friday. A panel of CDC advisors will vote Saturday, meaning shots for infants and preschoolers could be available as early as next week.
-
5 Things to Know Before the Stock Market Opens Wednesday
U.S. stock futures fell Wednesday, one day after the Dow and S&P 500 logged four-session winning streaks and the Nasdaq saw back-to-back gains.
-
FDA, CDC Expand Eligibility for Second Booster Shot to Americans Over 50
The FDA and CDC announced Tuesday that both agencies had expanded eligibility for a second booster shot of the Pfizer or Moderna coronavirus vaccines for all adults over the age of 50.
-
CDC Recommends Fourth Pfizer and Moderna Covid Vaccine Doses for People Age 50 and Older
The CDC and FDA made the decision without consulting their committees of independent vaccine experts.
-
Cramer's Lightning Round: Stanley Black & Decker Is a Buy
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
-
Moderna Wants to Give FDA ‘Flexibility' in Deciding Eligibility for 4th Covid Shot, CEO Says
“You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them,” CEO Stephane Bancel told CNBC.